Xeris Biopharma Holdings, Inc. Annual Revenues in USD from 2020 to 2021

Taxonomy & unit: us-gaap: USD
Description: Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary: Xeris Biopharma Holdings, Inc. quarterly/annual Revenues history and growth rate from 2020 to 2021.
Xeris Biopharma Holdings, Inc. Revenues for the quarter ending March 31, 2022 was $22.1M, a 169% increase year-over-year.
Xeris Biopharma Holdings, Inc. annual Revenues for 2021 was $49.6M, a 143% increase from 2020.

Revenues, Annual (USD)

Revenues, YoY Annual Growth (%)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
2021	$49.6M	+$29.2M	+143%	Jan 1, 2021	Dec 31, 2021	10-K	2022-03-11
2020	$20.4M			Jan 1, 2020	Dec 31, 2020	10-K	2022-03-11

* An asterisk sign (*) next to the value indicates that the value is likely invalid.